1969
DOI: 10.1002/cpt1969104449
|View full text |Cite
|
Sign up to set email alerts
|

Cardiogenic shock: A review

Abstract: A great expansion of interest has occurred in the syndrome of circulatory shock. The measurement of hemodynamic and metabolic variables in human beings and experimental animals now allows an orderly and integrated approach to the ill patient. In cardiogenic shock the minute output of the acutely iniured heart abruptly decreases with attendant fall in arterial blood pressure, tissue perfusion, and pH. Effective venous return to the right and left heart may be monitored by central venous pressure and pulmonary a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1971
1971
1980
1980

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 48 publications
0
6
0
Order By: Relevance
“…The present pharmacological basis for the therapeutic use of a-adrenoceptor blocking drugs in this situation is that, by antagonizing sympathetic vasoconstrictor tone (particularly at the venous end of the capillary bed), they increase peripheral tissue perfusion. Perlroth & Harrison (1969) have, however, questioned the value of a-adrenoceptor blocking drugs in cardiogenic shock on the grounds that, by lowering diastolic pressure, they may reduce coronary perfusion in patients with an exaggerated left ventricular enddiastolic pressure or with a ' fixed' coronary vascular resistance, a situation where perhaps autoregulation is absent.…”
Section: Lntroductionmentioning
confidence: 99%
“…The present pharmacological basis for the therapeutic use of a-adrenoceptor blocking drugs in this situation is that, by antagonizing sympathetic vasoconstrictor tone (particularly at the venous end of the capillary bed), they increase peripheral tissue perfusion. Perlroth & Harrison (1969) have, however, questioned the value of a-adrenoceptor blocking drugs in cardiogenic shock on the grounds that, by lowering diastolic pressure, they may reduce coronary perfusion in patients with an exaggerated left ventricular enddiastolic pressure or with a ' fixed' coronary vascular resistance, a situation where perhaps autoregulation is absent.…”
Section: Lntroductionmentioning
confidence: 99%
“…These symptoms have persisted to the present time with the recent addition of intravascular coagulation as a component of hemodynamic change (Wilson e^ al.., 1967;Hirshfeld and Fell, 1969). Blood pooling and perfusion also accompanies shock in a majority of cases (Perlroth and Harrison, 1969;Armstrong, 1970). Once the shock syndrome develops, phys iologic compensatory mechanisms are activated.…”
Section: Circulationmentioning
confidence: 99%
“…The primary beneficial effects of glucocorti-colds in shock may rest as much on their ability to maintain the integrity of cell membranes and subcellular particles, mitochondria, and lysosomes as upon their ability to influence the dynamics of the circulation (Lillehei et al, 1964). Perlroth and Harrison (1969) reported that corticosteroids are specific for the treatment of shock when it is due to adrenal insufficiency. Topel (1968b) reported that adrenal cortical steroids are associated with stress .…”
Section: Specific Catecholamine Influences Have Been Recognized Bymentioning
confidence: 99%
See 2 more Smart Citations